Your browser doesn't support javascript.
loading
Is glutamate associated with fear extinction and cognitive behavior therapy outcome in OCD? A pilot study.
Giménez, M; Cano, M; Martínez-Zalacaín, I; Real, E; Alonso, P; Segalàs, C; Munuera, J; Kegeles, L S; Weinstein, J J; Xu, X; Menchón, J M; Cardoner, N; Soriano-Mas, C; Fullana, M A.
Affiliation
  • Giménez M; Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, Feixa Llarga s/n, Hospitalet de Llobregat, 08907, Barcelona, Spain.
  • Cano M; Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental-CIBERSAM, Av. de Monforte de Lemos 5, 28029, Madrid, Spain.
  • Martínez-Zalacaín I; Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, Feixa Llarga s/n, Hospitalet de Llobregat, 08907, Barcelona, Spain.
  • Real E; Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental-CIBERSAM, Av. de Monforte de Lemos 5, 28029, Madrid, Spain.
  • Alonso P; Department of Clinical Sciences, School of Medicine, University of Barcelona, Casanova 143, 08036, Barcelona, Spain.
  • Segalàs C; Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, Feixa Llarga s/n, Hospitalet de Llobregat, 08907, Barcelona, Spain.
  • Munuera J; Department of Clinical Sciences, School of Medicine, University of Barcelona, Casanova 143, 08036, Barcelona, Spain.
  • Kegeles LS; Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, Feixa Llarga s/n, Hospitalet de Llobregat, 08907, Barcelona, Spain.
  • Weinstein JJ; Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental-CIBERSAM, Av. de Monforte de Lemos 5, 28029, Madrid, Spain.
  • Xu X; Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, Feixa Llarga s/n, Hospitalet de Llobregat, 08907, Barcelona, Spain.
  • Menchón JM; Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental-CIBERSAM, Av. de Monforte de Lemos 5, 28029, Madrid, Spain.
  • Cardoner N; Department of Clinical Sciences, School of Medicine, University of Barcelona, Casanova 143, 08036, Barcelona, Spain.
  • Soriano-Mas C; Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, Feixa Llarga s/n, Hospitalet de Llobregat, 08907, Barcelona, Spain.
  • Fullana MA; Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental-CIBERSAM, Av. de Monforte de Lemos 5, 28029, Madrid, Spain.
Eur Arch Psychiatry Clin Neurosci ; 270(8): 1003-1014, 2020 Dec.
Article in En | MEDLINE | ID: mdl-31432262
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cognitive Behavioral Therapy / Outcome Assessment, Health Care / Prefrontal Cortex / Glutamic Acid / Extinction, Psychological / Fear / Obsessive-Compulsive Disorder Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Eur Arch Psychiatry Clin Neurosci Year: 2020 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cognitive Behavioral Therapy / Outcome Assessment, Health Care / Prefrontal Cortex / Glutamic Acid / Extinction, Psychological / Fear / Obsessive-Compulsive Disorder Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Eur Arch Psychiatry Clin Neurosci Year: 2020 Document type: Article